Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.
about
Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.Suzuki coupling of potassium cyclopropyl- and alkoxymethyltrifluoroborates with benzyl chlorides.Butyrate histone deacetylase inhibitors.Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicitySolid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.Prodrugs for the treatment of neglected diseases.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity.Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers.Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.Direct alkylation of heteroaryls using potassium alkyl- and alkoxymethyltrifluoroborates.Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.
P2860
Q34181672-AF8F779F-0048-4E21-B9DC-2C6F262B414FQ35836362-93212102-BDCE-410F-AB71-D36420ED9E7FQ36574546-3BD58E76-164F-4B03-967A-9F4B78558DAAQ36609442-6A59B8C3-742C-43D2-8D89-A19C3165E46AQ36825153-7E2B11F5-5700-4E32-B19A-ED61C0DED0F4Q37096490-B4147420-668E-4ADD-898D-8B250A0E966BQ37157236-A26E6D97-4607-49B3-9046-149C1A1EEA71Q38743021-6E9EA496-90ED-4E42-BAEC-45EDFD4F9A3CQ39652513-16AC4D1F-6FD7-47D0-A12B-88091C109061Q41204019-3F2C94AC-43B2-4D85-84BB-6614534953BBQ42581818-508AFB11-2468-4C09-B516-54CA8B72904CQ42709341-E31816D9-DD71-41DD-B868-5C6E513F6944Q43247402-0E4E507C-3A14-4ED0-8C70-49FD66F457D2Q52781314-795D0C40-233B-4EA9-B292-78DA522CBBEC
P2860
Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@ast
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@en
type
label
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@ast
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@en
prefLabel
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@ast
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@en
P2093
P1476
Prodrugs of butyric acid. Nove ...... ing cancer and blood diseases.
@en
P2093
Cohen-Ohana M
Nudelman A
Rephaeli A
P356
10.1016/S0223-5234(00)01199-5
P577
2001-01-01T00:00:00Z